Varicose veins affect roughly 30% of the global population, presenting as swollen, twisted, and bulging pathways right beneath the skin's surface. Measuring at least 3 millimetres in diameter, these prominent blue or purple vessels are most commonly found in the calves, ankles, and feet, where the simple daily pressures of standing and walking place the heaviest burden on our circulatory system. While many people view varicose veins purely as a cosmetic frustration, they matter because they serve as a window into your deep vascular health. Far from being a surface-level flaw, they are frequently the first visible warning sign of a much more serious underlying condition known as Chronic Venous Insufficiency (CVI). To understand why this is a serious condition, it helps to understand why the normal functioning of veins is so critical. (Mal)function of the venous system In a healthy person, the cardiovascular system follows a predictable, highly efficient cycle: The ...

 Smartwatches have evolved from simple timekeeping devices into compact health-monitoring systems that generate data on sleep patterns, energy expenditure, and other physiological metrics. Among their most sought-after features is heart-rate monitoring. While wearable sensors can provide a useful estimate of heart rate after physical activity, can they reliably assess cardiovascular health? How accurately do they reflect an individual’s cardiac status? Understanding your Heart Rate Heart rate is the number of times the heart beats within a certain time period, usually a minute. For a healthy adult who is at rest, the heart rate is normally between 60 and 100 beats per minute (bpm). Tachycardia Our heart rate adjusts to the body’s changing metabolic demands throughout the day, whether climbing stairs or engaging in strenuous exercise. Such activity-related fluctuations are physiological and generally normal. During these episodes, you may temporarily experience tachycardia...

 Chest pain is notoriously complex, presenting with a wide spectrum of symptoms that often overlap across organ systems. Medical professionals frequently face the diagnostic challenge of differentiating between cardiac ischemia, respiratory pathologies, and gastrointestinal disorders. While conditions like Gastroesophageal Reflux Disease (GERD) and musculoskeletal strains can mimic acute coronary syndromes, they stem from entirely unrelated causes. However, more often than not, patients also experience tightness and squeezing pain in their chest, signalling the presence of cardiac pain or angina, which may indicate underlying issues such as coronary artery disease and so on. Prompt and accurate diagnosis of these presentations is critical to ensure patient safety, prevent unnecessary interventions, and direct individuals toward the appropriate clinical pathway. Clinical Indicators of Gastrointestinal Origin Dietary habits and digestive function heavily influence gastrointes...

 Heart blockages occur when the arteries carrying blood to the heart start narrowing. The heart receives less oxygen than what is required. In the early stages, this reduced supply is mild and inconsistent, which is why symptoms can be inconsistent and hard to pinpoint. Do consult a doctor if you are experiencing the following symptoms: 1.       Fatigue 2.       Shortness of breath during activities that have not seemed difficult before. 3.       Pressure in the middle of the chest. In a landmark trial conducted by the researchers from NYU Grossman School of Medicine and Stanford University, they present some important findings related to heart blockages and their treatment. Background of the ISCHEMIA study Funded by the National Heart, Lung, and Blood Institute, the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial studied patients with...

  What the Landmark ORBITA Trial Means for Patients, Cardiologists and the Future of Heart  Disease Management A Landmark Study That Sent Shockwaves Through Cardiology On 2 November 2017, The Lancet, one of the world's most prestigious medical journals, published a landmark clinical trial that has challenged one of the most deeply held beliefs in modern cardiology. The study, known as ORBITA (Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina), has generated intense debate among cardiologists across the world and may ultimately reshape the management of patients with stable coronary artery disease. For nearly four decades, angioplasty has been considered the preferred treatment for relieving chest pain in patients with stable angina. Although previous clinical trials had already demonstrated that angioplasty does not reduce the risk of future heart attacks or improve survival in stable patients, many physicians continued to ...